THPO and Thrombocytopenia: Although thrombopoietin agonists and targeted medicines are non-invasive alternatives for treating cirrhosis-related thrombocytopenia, clinical trials are being conducted to see if they may improve thrombocytopenia in cirrhotic patients [74].